Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 252

1.

Progressive transition of Epstein-Barr virus associated lymphoproliferative disease subtypes with the development of lung cancer.

Taoka K, Nannya Y, Yamamoto G, Sakatani T, Ota S, Fukayama M, Takahashi T, Kurokawa M.

Am J Hematol. 2009 Sep;84(9):600-3. doi: 10.1002/ajh.21479.

2.

[Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation].

Liu QF, Fan ZP, Luo XD, Zhang Y, Sun J.

Zhonghua Yi Xue Za Zhi. 2008 Dec 2;88(44):3123-6. Chinese.

PMID:
19159594
3.

Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.

Sato E, Ohga S, Kuroda H, Yoshiba F, Nishimura M, Nagasawa M, Inoue M, Kawa K.

Am J Hematol. 2008 Sep;83(9):721-7. doi: 10.1002/ajh.21247.

5.

Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.

Meerbach A, Wutzler P, Häfer R, Zintl F, Gruhn B.

J Med Virol. 2008 Mar;80(3):441-54. doi: 10.1002/jmv.21096.

PMID:
18205222
6.

Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.

Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS, Peh SC, Chan JK; CAEBV Study Group.

Pathol Int. 2008 Apr;58(4):209-17. doi: 10.1111/j.1440-1827.2008.02213.x. Review.

PMID:
18324913
7.

Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.

Kojima M, Morita Y, Nakamura N, Shimizu K, Murayama K, Nakamura S.

Pathol Res Pract. 2008;204(4):267-72. doi: 10.1016/j.prp.2007.11.007. Epub 2008 Jan 9.

PMID:
18187262
8.
9.

Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease.

Shimoyama Y, Yamamoto K, Asano N, Oyama T, Kinoshita T, Nakamura S.

Cancer Sci. 2008 Jun;99(6):1085-91. doi: 10.1111/j.1349-7006.2008.00813.x. Epub 2008 Apr 21. Review.

10.
11.

Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma.

Awaya N, Adachi A, Mori T, Kamata H, Nakahara J, Yokoyama K, Yamada T, Kizaki M, Sakamoto M, Ikeda Y, Okamoto S.

Leuk Res. 2006 Aug;30(8):1059-62. Epub 2005 Dec 2.

PMID:
16330097
12.

B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.

Dolcetti R.

Autoimmun Rev. 2007 Dec;7(2):96-101. Epub 2007 Mar 26. Review.

PMID:
18035317
13.

Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.

Johnson LR, Nalesnik MA, Swerdlow SH.

Am J Surg Pathol. 2006 Dec;30(12):1604-12.

PMID:
17122518
14.

Epstein Barr virus-associated lymphoproliferative-disorders primarily involving the skin.

Chai C, White WL, Shea CR, Prieto VG.

J Cutan Pathol. 1999 May;26(5):242-7.

PMID:
10408349
15.

Pre-emptive therapy with rituximab for prevention of Epstein-Barr virus-associated lymphoproliferative disease after hematopoietic stem cell transplantation.

Gruhn B, Meerbach A, Häfer R, Zell R, Wutzler P, Zintl F.

Bone Marrow Transplant. 2003 Jun;31(11):1023-5.

PMID:
12774054
16.

Abdominal-pelvic lymphoproliferative disease after lung transplantation: presentation and outcome.

Hachem RR, Chakinala MM, Yusen RD, Lynch JP, Aloush AA, Patterson GA, Trulock EP.

Transplantation. 2004 Feb 15;77(3):431-7.

PMID:
14966421
17.

Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini review.

Shimoyama Y, Oyama T, Asano N, Oshiro A, Suzuki R, Kagami Y, Morishima Y, Nakamura S.

J Clin Exp Hematop. 2006 Mar;46(1):1-4. Review.

18.

The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groups.

Cho EY, Kim KH, Kim WS, Yoo KH, Koo HH, Ko YH.

J Korean Med Sci. 2008 Apr;23(2):185-92. doi: 10.3346/jkms.2008.23.2.185.

19.

Isolated cerebral manifestation of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: a case of clinical and diagnostic challenges.

Kittan NA, Beier F, Kurz K, Niller HH, Egger L, Jilg W, Andreesen R, Holler E, Hildebrandt GC.

Transpl Infect Dis. 2011 Oct;13(5):524-30. doi: 10.1111/j.1399-3062.2011.00621.x. Epub 2011 Mar 13.

PMID:
21395956
20.

Fatal outcome in a patient developing Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD) without measurable disease.

Ringhoffer M, Döhner K, Scheil S, Wilts H, Mertens T, Grimminger W, Döhner H, Bunjes D.

Bone Marrow Transplant. 2001 Sep;28(6):615-8.

Supplemental Content

Support Center